ArticleTechnical innovations & patient support in radiation oncology2026
Evaluating the dosimetric impact of intrafraction shifts on critical OAR doses for spine SBRT using an In-House simulator.
Article in Technical innovations & patient support in radiation oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study evaluated the dosimetric impact of intrafraction motion during spine SBRT by developing a novel dose deviation simulator capable of analyzing translations and rotations in all six degrees of freedom. We retrospectively assessed the treatment plans from 18 spine SBRT patients treated at our institution with 24 Gy in two fractions by simulating shifts of 0.5-2 mm (translations) and 0.5-2° (rotations), and calculating changes in D0.03 cc to spinal cord, cord PRV, and thecal sac. Translational shifts, particularly in the vertical direction, produced the greatest observed deviations, with a 2 mm vertical shift yielding median increases, reported as percent of prescription dose, of 20.6% (4.93 Gy) to thecal sac D0.03 cc and 6.5% (1.55 Gy) to spinal cord D0.03 cc. Our simulator's accuracy was validated against treatment planning system-based forward calculations, showing mean differences of -1.3% ± 3.5% between the two systems. This study provides practical reference values to assist clinicians in rapidly evaluating the clinical significance of observed intrafraction motion. These findings may streamline decision-making during treatment and highlight the importance of precise positioning and motion monitoring in spine SBRT.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.